Flexible selection of a single treatment incorporating short‐term endpoint information in a phase II/III clinical trial

E-ISSN： 1097-0258|34|23|3104-3115

ISSN： 0277-6715

Source： STATISTICS IN MEDICINE, Vol.34, Iss.23, 2015-10, pp. : 3104-3115

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Single‐arm phase II trial design under parametric cure models

PHARMACEUTICAL STATISTICS: THE JOURNAL OF APPLIED STATISTICS IN THE PHARMACEUTICAL INDUSTRY, Vol. 14, Iss. 3, 2015-05 ,pp. : 226-232

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Influence of Single‐Dose and Short‐Term Administration of Quercetin on the Pharmacokinetics of Midazolam in Humans

JOURNAL OF PHARMACEUTICAL SCIENCES (ELECTRONIC), Vol. 104, Iss. 9, 2015-09 ,pp. : 3199-3207

John Wiley & Sons Inc

Access to resources Recommend Favorite

A Phase I/II adaptive design for heterogeneous groups with application to a stereotactic body radiation therapy trial

PHARMACEUTICAL STATISTICS: THE JOURNAL OF APPLIED STATISTICS IN THE PHARMACEUTICAL INDUSTRY, Vol. 14, Iss. 4, 2015-07 ,pp. : 302-310

John Wiley & Sons Inc

Access to resources Recommend Favorite

A Bayesian dose‐finding design for phase I/II clinical trials with nonignorable dropouts

STATISTICS IN MEDICINE, Vol. 34, Iss. 10, 2015-05 ,pp. : 1721-1732

John Wiley & Sons Inc

Access to resources Recommend Favorite

Platinum(II)–Gadolinium(III) Complexes as Potential Single‐Molecular Theranostic Agents for Cancer Treatment

ANGEWANDTE CHEMIE, Vol. 126, Iss. 48, 2014-11 ,pp. : 13441-13444

John Wiley & Sons Inc

Access to resources Recommend Favorite